printable article

Originally published November 3 2013

Scientists finally admit H1N1 vaccine causes increased risk of Guillain-Barre syndrome

by Ethan A. Huff, staff writer

(NaturalNews) A new study published in the Journal of the American Medical Association (JAMA) admits that the vaccine widely administered for H1N1, also known as "swine flu," is linked to causing neurological damage in the form of Guillain-Barre syndrome. The findings confirm several earlier studies in both the U.S. and U.K. that also linked the H1N1 vaccine to severe neurological damage.

Reuters Health reports that, for the new study, Philippe De Wals of Laval University in Quebec City and his colleagues evaluated rates of Guillain-Barre in Canadians during the six months following the initial roll out of H1N1 in Quebec. Upon review, the team says it observed a definite increase in Guillain-Barre cases associated with the vaccine.

For those who are unaware of what Guillain-Barre actually is, the condition is marked by an autoimmune reaction where the body's immune system mistakenly attacks the nervous system as if it is a foreign invader, which can cause severe nerve inflammation, muscle weakness, paralysis, and even death. Guillain-Barre was also widely observed following the mass vaccination campaigns for swine flu back in 1976.

The Canadian study confirms what the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) determined about the H1N1 vaccine back in 2010. The agency, which is akin to the U.S. Food and Drug Administration (FDA) in the U.S., issued a public statement at that time admitting that the H1N1 vaccine is linked to "a slightly elevated risk of GBS." (

The U.K.'s Health Protection Agency (HPA) also reportedly sent a confidential letter to roughly 600 senior neurologists back in 2009 warning them about the H1N1 vaccine's definitive link to Guillain-Barre. None of this important information, which was clearly meant to remain a secret, was distributed for public health purposes during that time. (

However, data gathered by the U.S. Centers for Disease Control and Prevention (CDC) following the massive roll out of H1N1 vaccines in the U.S. back in 2009 also linked the jab to Guillain-Barre. Though scientists and government authorities tried to downplay the findings and make them appear as though the risk of Guillain-Barre was inconsequential (, the cat was out of the bag, as there was no denying that the H1N1 vaccine is clearly linked to neurological damage.

Just ask 14-year-old Jordan McFarland, a high school athlete from Alexandria, Virginia, who developed Guillain-Barre syndrome just hours after getting his H1N1 jab. Jordan reportedly suffered extreme weakness and inability to walk following the vaccine, and developed severe headaches and muscle spasms. The young boy even had to use a walker for several months in order to maintain some kind of mobility. (

Sources for this article include:

All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit